
Advertisement|Remove ads.
Oscar Health (OSCR) shares traded nearly 5% higher on Tuesday morning after the company projected fiscal 2026 revenue well above the FY2025 level reported alongside its fourth-quarter results.
The company forecast fiscal 2026 revenue between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025. However, the health insurer’s fourth-quarter (Q4) total revenue came in at $2.81 billion, significantly below the Street estimates of $3.12 billion, according to Fiscal.ai data. Oscar also reported a loss of $1.24 per share, wider than the estimates of a loss of $0.92 per share.
The company’s medical loss ratio (MLR) was 95.1%, meaning 95.1% of total premiums paid by policyholders went toward claims, with the remaining 4.9% retained by the insurer. It was 88.1% last year.
Advertisement|Remove ads.
As of Feb. 1, 2026, Oscar served about 3.4 million members.
CFO Scott Blackley said in a call with analysts that the firm expects to meaningfully improve financial performance and return to profitability in 2026.
“We expect earnings from operations to be in the range of $250 million to $450 million, a significant improvement of nearly $750 million year-over-year, implying an operating margin of approximately 1.9% at the midpoint. Adjusted EBITDA is expected to be approximately $115 million higher than earnings from operations,” Blackley said.
Advertisement|Remove ads.
Oscar Health posted a net loss in five of the last six quarters, according to Koyfin data.
On February 6, the company secured a $475 million, three-year revolving credit facility, which Blackley said will provide flexibility to support long-term growth and expand adoption in the individual market.
Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day back, amid ‘extremely high’ message volumes. OSCR was among the top trending tickers at the time of writing.
Advertisement|Remove ads.

One user was bullish about the guidance, expecting the stock price to double over the coming weeks.
Advertisement|Remove ads.
Another user highlighted that they are adding to their position.
Year-to-date, the stock has declined around 10%
Advertisement|Remove ads.
Read also: SIDU Stock Gained 5% In Pre-Market Today – What Is The Deal With Simera Sense About?
For updates and corrections, email newsroom[at]stocktwits[dot]com
Comments posted here will also appear on symbol pages.